HIGHLIGHTS
- who: Ines Bojanic and colleagues from the Humanitas Research, Italy University of Basel, Switzerland have published the paper: Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers, in the Journal: (JOURNAL)
- what: The response to prolonged therapy in 24 patients from this study group was reported by Greinix et al, with progressive improvement in TSS, 31% CR/PR in cutaneous cGvHD, and 70% CR/PR in mucosal symptoms at 24 weeks . The positive correlation between ECP treatment, Treg frequency and clinical improvement has not been consistently observed throughout . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.